Epidermal growth factor receptors in non-small cell lung cancer
- PMID: 3038157
- PMCID: PMC2001730
- DOI: 10.1038/bjc.1987.104
Epidermal growth factor receptors in non-small cell lung cancer
Abstract
The epidermal growth factor receptor is homologous to the oncogene erb-beta and is the receptor for a class of tumour growth factors (TGF-alpha). The clinical correlations with its expression were studied in 77 non-small cell lung cancers (NSCLC). They were stained for epidermal growth factor receptor (EGFr) by means of an indirect immunoperoxidase technique using a monoclonal antibody against the receptor. Normal lung tissue and normal bronchus were stained for comparison. Cancer tissue showed significantly increased staining compared to normal lung (P less than 0.05). Staining for EGFr in 40 squamous carcinomas was significantly stronger than in 37 specimens of other types of NSCLC (P less than 0.05), and staining in stage three NSCLC was stronger than in stage 1 and 2 (P less than 0.05). These results suggest that the presence of a high intensity of staining for EGF receptor is associated with spread of human non-small cell lung cancer and this receptor may be a suitable target for therapy.
Similar articles
-
Cetuximab in advanced non-small cell lung cancer.Crit Rev Oncol Hematol. 2006 Aug;59(2):139-49. doi: 10.1016/j.critrevonc.2006.02.006. Epub 2006 Jun 23. Crit Rev Oncol Hematol. 2006. PMID: 16806963 Review.
-
Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists.Chest. 2005 Dec;128(6):3975-84. doi: 10.1378/chest.128.6.3975. Chest. 2005. PMID: 16354869 Review.
-
Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.Oncol Rep. 2000 May-Jun;7(3):603-7. doi: 10.3892/or.7.3.603. Oncol Rep. 2000. PMID: 10767376
-
Expression of epidermal growth factor receptor (EGF-R) in human lung tumours.Br J Cancer. 1986 Aug;54(2):265-9. doi: 10.1038/bjc.1986.172. Br J Cancer. 1986. PMID: 3017396 Free PMC article.
-
Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival.Br J Cancer. 1989 May;59(5):746-9. doi: 10.1038/bjc.1989.156. Br J Cancer. 1989. PMID: 2544220 Free PMC article.
Cited by
-
Imidazole[1,5-a]pyridine derivatives as EGFR tyrosine kinase inhibitors unraveled by umbrella sampling and steered molecular dynamics simulations.Sci Rep. 2024 May 28;14(1):12218. doi: 10.1038/s41598-024-62743-3. Sci Rep. 2024. PMID: 38806555 Free PMC article.
-
Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinase.Front Pharmacol. 2024 Jan 11;14:1231671. doi: 10.3389/fphar.2023.1231671. eCollection 2023. Front Pharmacol. 2024. PMID: 38273823 Free PMC article.
-
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab.Cell Rep Med. 2023 Aug 15;4(8):101142. doi: 10.1016/j.xcrm.2023.101142. Epub 2023 Aug 8. Cell Rep Med. 2023. PMID: 37557179 Free PMC article.
-
Mutability of druggable kinases and pro-inflammatory cytokines by their proximity to telomeres and A+T content.PLoS One. 2023 Apr 27;18(4):e0283470. doi: 10.1371/journal.pone.0283470. eCollection 2023. PLoS One. 2023. PMID: 37104389 Free PMC article.
-
Coupled folding-upon-binding of human tumor suppressor MIG6 to lung cancer EGFR kinase domain and molecular trimming/stapling of MIG6-derived β-hairpins to target the coupling event.Eur Biophys J. 2023 Feb;52(1-2):17-25. doi: 10.1007/s00249-022-01624-x. Epub 2022 Dec 22. Eur Biophys J. 2023. PMID: 36547692
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous